Abemaciclib: Uses, Dosage, Side Effects, Warnings - Drugs.com
WEBJun 2, 2023 · What is abemaciclib? Abemaciclib belongs to a class of medications called kinase inhibitors. Abemaciclib works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Abemaciclib - Wikipedia
WEBAbemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6. It was designated as a breakthrough therapy for breast cancer by the US Food and Drug Administration (FDA) in October ...
Abemaciclib (Oral Route) Description and Brand Names - Mayo Clinic
WEBMay 1, 2024 · Abemaciclib is used together with tamoxifen or an aromatase inhibitor (eg, anastrozole, exemestane, letrozole) to treat hormone receptor (HR)-positive, HER-2 negative, node-positive, early breast cancer with a …
Abemaciclib - NCI - National Cancer Institute
WEBThis page contains brief information about abemaciclib (Verzenio) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Abemaciclib (Verzenios) | Breast Cancer Now
WEBWhen used to treat breast cancer, abemaciclib is taken alongside hormone (endocrine) therapy. Abemaciclib is the drug’s non-branded name. Its brand name is Verzenios. It belongs to a group of drugs called CDK (cyclin dependent kinase) inhibitors.
Abemaciclib: MedlinePlus Drug Information
WEBAbemaciclib is used in combination with tamoxifen (Soltamox) or an aromatase inhibitor such as anastrozole (Arimidex), exemestane (Aromasin), or letrozole (Femara) to treat a certain type of hormone receptor-positive, early breast cancer.
Abemaciclib May Be Option for Early-Stage Breast Cancer
WEBUPDATE: On October 12, 2021, the Food and Drug Administration (FDA) approved abemaciclib (Verzenio) in combination with endocrine therapy (either an aromatase inhibitor or tamoxifen) following surgery to treat some people with HR-positive, HER2-negative breast cancer.
FDA approves abemaciclib with endocrine therapy for early breast …
WEBOn October 12,2021, the Food and Drug Administration approved abemaciclib (Verzenio,Eli Lilly and Company)with endocrine therapy (tamoxifen or an aromatase inhibitor) for adjuvant treatment of...
abemaciclib oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
WEBGeneric Name: abemaciclib. This medication is used to treat certain types of breast cancer. Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs...
Abemaciclib (Verzenois) | Cancer Research UK
WEBApr 8, 2024 · Abemaciclib is a type of targeted cancer drug. You pronounce it as a-bee-ma-sye-klib. It is also known as Verzenios. It is a treatment for breast cancer that has: spread to another part of the body (secondary or metastatic breast cancer)
- Some results have been removed
Skip to content